Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS) (Q65366667)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS) |
clinical trial |
Statements
A Phase II Study Evaluating the Oral Smoothened Inhibitor PF-04449913 in Patients With Myelodysplastic Syndrome (MDS) (English)
0 references
29 August 2013
0 references
31 January 2016
0 references
35
0 references
18 year
0 references